Friday, February 04, 2022 7:12:20 AM
Net loss of $44M > no revenues! ( over 9 month period)
ACLX
ACLX
New York Yankees and Duke Basketball
Recent ACLX News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/28/2026 08:29:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/28/2026 08:24:51 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 04/28/2026 08:24:11 PM
- Form POSASR - Post-effective Amendment to an automatic shelf registration statement • Edgar (US Regulatory) • 04/28/2026 08:17:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/28/2026 08:05:32 PM
- Form SC 14D9/A - Solicitation, recommendation statements: [Amend] • Edgar (US Regulatory) • 04/28/2026 01:04:06 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 04/24/2026 08:38:08 PM
- Form SC 14D9/A - Solicitation, recommendation statements: [Amend] • Edgar (US Regulatory) • 04/21/2026 12:31:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 09:00:14 PM
- Form SC 14D9/A - Solicitation, recommendation statements: [Amend] • Edgar (US Regulatory) • 04/17/2026 01:12:29 PM
- Form SC 14D9/A - Solicitation, recommendation statements: [Amend] • Edgar (US Regulatory) • 04/01/2026 08:50:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/19/2026 10:26:45 PM
- Form SC 14D9 - Solicitation, recommendation statements • Edgar (US Regulatory) • 03/06/2026 10:20:29 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 03/06/2026 05:57:46 PM
- Immunotherapy Delivers Across Tumor Types as Oncology Market Eyes $750 Billion • PR Newswire (Canada) • 03/03/2026 02:00:00 PM
- Immunotherapy Delivers Across Tumor Types as Oncology Market Eyes $750 Billion • PR Newswire (US) • 03/03/2026 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2026 12:51:45 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/26/2026 12:49:56 AM
- Form SC14D9C - Written communication relating to third party tender offer • Edgar (US Regulatory) • 02/23/2026 09:07:11 PM
- Form SC14D9C - Written communication relating to third party tender offer • Edgar (US Regulatory) • 02/23/2026 09:06:20 PM
